Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Kochar B, Martin CF, Kappelman MD, Spiegel BM, Chen W, Sandler RS, Long MD.

Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.240. [Epub ahead of print]

PMID:
28853727
2.

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS.

Aliment Pharmacol Ther. 2017 Jul;46(2):162-168. doi: 10.1111/apt.14125. Epub 2017 May 3.

PMID:
28470787
3.

Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Barnes EL, Herfarth HH, Sandler RS, Chen W, Jaeger E, Nguyen VM, Robb AR, Kappelman MD, Martin CF, Long MD.

Inflamm Bowel Dis. 2017 Jul;23(7):1218-1224. doi: 10.1097/MIB.0000000000001119.

PMID:
28426474
4.

Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD.

Inflamm Bowel Dis. 2017 Jun;23(6):875-881. doi: 10.1097/MIB.0000000000001121.

PMID:
28426473
5.

Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.

Kochar B, Long MD, Galanko J, Raffals LE, Ananthakrishnan A, Sandler RS.

Inflamm Bowel Dis. 2017 Jul;23(7):1187-1194. doi: 10.1097/MIB.0000000000001115.

PMID:
28410340
6.

The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.

Long MD, Smiraglia DJ, Campbell MJ.

Biomolecules. 2017 Feb 14;7(1). pii: E15. doi: 10.3390/biom7010015. Review.

7.

Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.

Singh PK, van den Berg PR, Long MD, Vreugdenhil A, Grieshober L, Ochs-Balcom HM, Wang J, Delcambre S, Heikkinen S, Carlberg C, Campbell MJ, Sucheston-Campbell LE.

BMC Genomics. 2017 Feb 6;18(1):132. doi: 10.1186/s12864-017-3481-4.

8.

Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.

Abdalla MI, Sandler RS, Kappelman MD, Martin CF, Chen W, Anton K, Long MD.

Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.

PMID:
28092305
9.

Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.

Long MD, Campbell MJ.

J Steroid Biochem Mol Biol. 2017 Oct;173:130-138. doi: 10.1016/j.jsbmb.2016.12.013. Epub 2016 Dec 24.

PMID:
28027912
10.

miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.

Yates C, Long MD, Campbell MJ, Sucheston-Campbell L.

Front Biosci (Landmark Ed). 2017 Jan 1;22:212-229.

PMID:
27814612
11.
12.

The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients.

Abdalla MI, Sandler RS, Kappelman MD, Martin CF, Chen W, Anton K, Long MD.

Inflamm Bowel Dis. 2016 Nov;22(11):2658-2664.

PMID:
27661669
13.

Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.

Herfarth HH, Jackson S, Schliebe BG, Martin C, Ivanova A, Anton K, Sandler RS, Long MD, Isaacs KL, Osterman MT, Sands BE, Higgins PD, Lewis JD.

Inflamm Bowel Dis. 2017 Jan;23(1):14-22. doi: 10.1097/MIB.0000000000000907.

PMID:
27598744
14.

Reply to Dai et al.

Gaines LS, Kappelman MD, Long MD.

Am J Gastroenterol. 2016 Aug;111(8):1207-8. doi: 10.1038/ajg.2016.237. No abstract available.

PMID:
27481427
15.

Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H.

J Clin Gastroenterol. 2017 Jul;51(6):508-511. doi: 10.1097/MCG.0000000000000604.

PMID:
27433811
16.

Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis.

Cotton CC, Baird D, Sandler RS, Long MD.

Inflamm Bowel Dis. 2016 Jul;22(7):1631-8. doi: 10.1097/MIB.0000000000000800.

17.

Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.

Kochar B, Aldridge M, Cook SF, Bright R, Mallette M, Moniz H, Shah SA, LeLeiko NS, Shapiro J, Sands BE, Chen W, Jaeger E, Galanko J, Long MD, Martin CF, Sandler RS, Kappelman MD.

J Med Internet Res. 2016 Jun 3;18(6):e124. doi: 10.2196/jmir.5655.

18.

Pan-cancer analyses of the nuclear receptor superfamily.

Long MD, Campbell MJ.

Nucl Receptor Res. 2015 Dec;2. pii: 101182. Epub 2015 Dec 15.

19.

Patient-Reported Outcomes Measurement Information System in Children with Crohn's Disease.

Arvanitis M, DeWalt DA, Martin CF, Long MD, Chen W, Jaeger B, Sandler RS, Kappelman MD.

J Pediatr. 2016 Jul;174:153-159.e2. doi: 10.1016/j.jpeds.2016.03.069. Epub 2016 May 2.

20.

Shifting Away From Estrogen-Containing Oral Contraceptives in Crohn's Disease.

Long MD, Hutfless S.

Gastroenterology. 2016 Jun;150(7):1518-1520. doi: 10.1053/j.gastro.2016.04.032. Epub 2016 Apr 29. No abstract available.

PMID:
27138980

Supplemental Content

Support Center